Zobrazeno 1 - 10
of 19
pro vyhledávání: '"E. S. Zholobova"'
Autor:
L. I. Alekseeva, O. N. Anoshenkova, N. G. Dolganova, E. S. Zholobova, E. V. Zonova, S. A. Lapshina, M. A. Korolev, L. V. Menshikova, P. A. Shesternya, Yu. P. Chasovskikh
Publikováno v:
Современная ревматология, Vol 17, Iss 4, Pp 115-119 (2023)
At the meeting of the Expert Council on May 20, the safety of treatment for patients with osteoarthritis (OA), the most common form of joint disease, was discussed. The first step in the treatment of OA should be the administration of symptomatic del
Externí odkaz:
https://doaj.org/article/3f3f7c327d374ac6b6b279e6e795ac68
Publikováno v:
Сеченовский вестник, Vol 0, Iss 3, Pp 59-62 (2022)
The case report a psoriatic arthritis patient (disfiguring form, high laboratory values, changes of the skin and nails) treated with methotrexate. The drug demonstrated high efficacy resulting in stable sustained remission of articular syndrome, doc
Externí odkaz:
https://doaj.org/article/8500445609424920a8d3da1a84d88eba
Publikováno v:
Сеченовский вестник, Vol 0, Iss 2, Pp 59-64 (2022)
RETRACTED ARTICLEThe goal of this article is to provide an overview and comparison of published data on PsA with information obtained in the survey. A survey was conducted of 24 patients with PsA. Identified terms of formation of articular and cutane
Externí odkaz:
https://doaj.org/article/51aa529548504b24bc9fa0bd9a09265e
Autor:
E. S. Zholobova, М. N. Nikolaeva, S. N. Chebysheva, A. V. Meleshkina, O. Yu. Loskutova, L. A. Galstyan, E. Yu. Afonina
Publikováno v:
Современная ревматология, Vol 12, Iss 3, Pp 98-102 (2018)
The paper discusses whether biological agents (BAs) may be used as monotherapy. The combination of different BAs and methotrexate (MTX) allows a good result in patients with juvenile idiopathic arthritis refractory to standard antirheumatic therapy.
Externí odkaz:
https://doaj.org/article/3b74946d3ea34ea1bcf1b58bd5499016
Autor:
O. Yu. Konopel'ko, E. S. Zholobova, M. N. Nikolaeva, O. S. Rozvadovskaya, V. Ya. El'yashevich, E. Yu. Afonina
Publikováno v:
Вопросы современной педиатрии, Vol 12, Iss 6, Pp 115-119 (2013)
Aim: to assess efficacy and safety of etanercept in treatment of various types of juvenile idiopathic arthritis in children under conditions of real clinical practice. Patients and methods: 52 children were included into the study, among them 16 were
Externí odkaz:
https://doaj.org/article/004f5088a45d4858b490b7c90e5205ca
Publikováno v:
Вопросы современной педиатрии, Vol 11, Iss 6, Pp 142-146 (2012)
A history case of a female patient with juvenile idiopathic arthritis, resistant to steroids and methotrexate and secondary resistance to infliximab, is represented in this article. Switching to another tumor necrosis factor-alpha inhibitor — adali
Externí odkaz:
https://doaj.org/article/3331ab6fa4894daeb6bc5363651ff18c
Autor:
E. S. Zholobova, O. Yu. Konopel'ko, D. V. Dagbaeva, A. V. Bunin, O. S. Rozvadovskaya, M. N. Nikolaeva, V. Ya. El'yashevich
Publikováno v:
Вопросы современной педиатрии, Vol 11, Iss 3, Pp 120-125 (2012)
The article includes the results of observation of patients with resistant forms of juvenile arthritis, who have received treatment with infliximab in the period of time since 2004 till 2011. The drug was administered to 41 patients: 19 with systemic
Externí odkaz:
https://doaj.org/article/a2bb2b6e55744d9aa929172103ab2fc1
Autor:
E. S. Zholobova
Publikováno v:
Педиатрическая фармакология, Vol 10, Iss 6, Pp 82-84 (2013)
The article presents a case of complicated diagnostics of systemic juvenile idiopathic (rheumatoid) arthritis (JIA) starting with a fever of unclear genesis. Efficacy of interleukin 6 inhibitor tocilizumab for treating the systemic JIA resistant to g
Externí odkaz:
https://doaj.org/article/6c62ed94153d4e2185924d46192f4dff
Autor:
K. V. Aleksanyan, E. S. Zholobova, S. N. Chebysheva, A. V. Meleshkina, M. N. Nikolaeva, E. Yu. Popova, L. A. Galstyan
Publikováno v:
Rossijskij Vestnik Perinatologii i Pediatrii, Vol 65, Iss 4, Pp 108-116 (2020)
Introduction. Juvenile psoriatic arthritis is a chronic inflammatory disease accounting for 3-10% of all juvenile arthritis. Genetically engineered biological medications, particularly Etanercept, proved to be effective and safe in the adult patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae2529d9e50297ebfea45bdffea4b4ed
https://www.ped-perinatology.ru/jour/article/view/1209
https://www.ped-perinatology.ru/jour/article/view/1209
Autor:
L. A. Galstyan, E. S. Zholobova, S. N. Chebysheva, A. V. Meleshkina, V. A. Seraya, O. Yu. Loskutova
Publikováno v:
Rossijskij Vestnik Perinatologii i Pediatrii, Vol 64, Iss 2, Pp 30-37 (2019)
Rheumatoid uveitis is a serious problem in rheumatology and ophthalmology due to the peculiarities of the disease – an undistinguished beginning, chronic course and a high incidence of disabling complications. The article analyzes various data on t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4979d3486800d97236925e8ff4ad7355
https://doi.org/10.21508/1027-4065-2019-64-2-30-37
https://doi.org/10.21508/1027-4065-2019-64-2-30-37